netFormulary NHS
Coastal West Sussex
Local Health Economy Formulary
 Introduction

Welcome to the Coastal West Sussex Local Health Economy Formulary

If the product you search for is not found, it is currently non-formulary, and should not be routinely prescribed.

Useful Links

Effective Shared Care Agreements (ESCAs) Adult nutrition guidance South Central Antimicrobial Network
Area Prescribing Committee (APC) CWS formulary application forms NICE Technology appraisals adherence checklist
Patient Resources Keeping Tabs Newsletter Infant Feeding Guidelines
Specials Guidance

Policies, Guidelines and Pathways

CWS CCG Website
Continence Formulary Dressings Formulary Blue Coding – Information sheets
Prescribing Quality Review Scheme (PQRS) National Reporting and Learning System (NRLS) Sussex Partnership Foundation Trust (SPfT) Link
Medicines Supply Updates Medicines Safety Information Self Care
Individual Funding Requests Download net formulary from Apple IOS Store Google Play net formulary

 

News Feed

August 2019 - Availability of Emerade 0.3mg and Emerade 0.5mg Adrenaline Auto-Injectors:

Emerade (adrenaline auto-injector devices) will be subject to short term disruption to supply.  The manufacturer (Bausch & Lomb) states:

  • Emerade 500 microgram is out of stock until the 28 August 2019.
  • Emerade 300 microgram has limited supplies remaining but will be out of stock from early-mid August with further supplies expected by 30 September 2019.

Supply disruption alert from the Department of Health and Social Care

MHRA Adrenaline auto-injectors: updated advice after European review

If an alternative brand is prescribed,  the patient or carer will need to be trained on how to administer the new auto-injector.

 


June 2019 - Revised continence formulary:


May 2019 - Revised CWS Position Statement regarding Freestyle Libre®:


April 2019 – Labetalol tablets (all strengths) supply issue:

  • DHSC has been made aware of a supply issue for all strengths of labetalol tablets and as a result, supplies will be very limited from April until early-mid May. Prescribers should be aware that no new patients should be commenced on labetalol during this time. Patients who do not have sufficient supplies to last until early May and who are unable to obtain supplies of labetalol will need to be switched to an appropriate alternative treatment during this time. Link to full article on CWS CCG website


April 2019 – Levomepromazine 25mg/ml injection supply issue:

  • Sanofi informed NHS England and DHSC on 5th April 2019 that they are going out of stock this week of levomepromazine 25mg/ml injection and new stock is expected to be available from the end of April. The only other UK supplier, Wockhardt, have informed us that due to the unexpected increase in demand, they will also go out of stock of levomepromazine injection, with further stock expected at the end of April. Wockhardt have confirmed the remaining stock which is held at Alliance will be ring-fenced for primary care use only. Stock at Alliance is limited and will not last until the end of April. Link to full article on CWS CCG website

February 2019 - Discontinuation of Cilest® :

  • The manufacturer of Cilest® (norgestimate and ethinyl estradiol) has advised that it will be discontinued in July 2019. They state that this was a commercial decision and stressed that there are no safety, efficacy or quality issues with the product. Current supplies are expected to last until mid-July 2019. Cilique® and Lizinna® have been added to the CWS formulary to replace Cilest® as direct comparables.


>>> more news

ABOUT THE COASTAL WEST SUSSEX LOCAL HEALTH ECONOMY FORMULARY

The Coastal West Sussex local health economy formulary is the output of processes to support the managed introduction, utilisation or withdrawal of healthcare treatments in Coastal West Sussex. It is managed through the Coastal West Sussex Area Prescribing Committee and applies to all prescribers across the local health economy including Coastal West Sussex Clinical Commissioning Group, Western Sussex Hospitals NHS Foundation Trust, Sussex Partnership NHS Foundation Trust and Sussex Community NHS Trust.

The formulary is now up to date with respect to all the traffic light document information as well as the following currently ratified full BNF therapeutic chapters:

-Musculoskeletal and joint diseases
-Continence
-Urology
-Low Molecular Weight Heparins
-Dermatology
-Dressings
-Respiratory
-Ear, nose, and oropharynx
-Infections

The following sections have been ratified by CWS APC but are only available as standalone documents under the useful links (supporting formulary documents) currently:

-Oral Nutrional Supplements

All NICE positively appraised medicines are automatically included within the formulary (where clinically appropriate) and these can be accessed via the NICE technology appraisal adherence checklist link above. These medicines are available for clinicians to prescribe, should they choose to, in a way that supports safe and clinically appropriate practice. Prescribing responsibility is defined within the traffic light system.

The technology in a NICE technology appraisal may not be the only treatment for a particular condition. If a NICE technology appraisal recommends use of a technology, it is as an option for the treatment of a disease or condition. This means that the technology should be available for a patient who meets the clinical criteria set out in the guidance, subject to the clinical judgement of the treating clinician. The NHS must provide funding and resources when the clinician concludes and the patient agrees that the recommended technology is the most appropriate to use, based on a discussion of all available treatments

The Medicines Management team are always happy to receive any feedback on the formulary. Please use the feedback button at the top of the page if you wish to contact us in relation to the formulary.

SITE DISCLAIMER
Every care has been taken in the compilation and publication of the content on our website. However, Coastal West Sussex Area Prescribing Committee (and its consituent NHS members) will not be held responsible for any loss, damage or inconvenience caused as a result of any inaccuracy or error within these pages.

MEMBERS OF THE PUBLIC
Please note that all material in this site is aimed at healthcare professionals. Members of the public seeking advice on any medicine-related matters are encouraged to contact NHS 111 or speak with their GP, pharmacist or nurse.

EXTERNAL LINKS
Links are provided for information and convenience only. We cannot accept responsibility for the sites linked to, or the information found there. A link does not imply an endorsement of a site; likewise, not linking to a particular site does not imply lack of endorsement. Links to NHS member organisational policies or guidelines may not be accessible from all locations

VIRUS PROTECTION
We cannot accept any responsibility for any loss, disruption or damage to your data or your computer system that may occur while using material derived from this website.


NetFormulary
   Visits = 347582
   Last updated: 18/09/2019 12:25:57
    Download net formulary from Apple IOS Store  Google Play net formulary